Wilhelm Schanzer
Overview
Explore the profile of Wilhelm Schanzer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
277
Citations
1427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dib J, Tretzel L, Piper T, Lagojda A, Kuehne D, Schanzer W, et al.
Clin Mass Spectrom
. 2024 Aug;
6:13-20.
PMID: 39193415
AdipoRon and 112254 represent two known synthetic adiponectin receptor (adipoR) agonists. Although AdipoRon is the more potent compound, both have physiological properties that are similar to adiponectin - an adipokine...
2.
Breuer J, Thomas A, Delahaut P, Schanzer W, Geyer H, Thevis M
Anal Bioanal Chem
. 2022 Nov;
415(4):669-681.
PMID: 36441233
Potential scenarios as to the origin of minute amounts of banned substances detected in doping control samples have been a much-discussed problem in anti-doping analysis in recent years. One such...
3.
Piper T, Fussholler G, Schanzer W, Thevis M
Rapid Commun Mass Spectrom
. 2022 Jun;
36(17):e9343.
PMID: 35737649
Rationale: The anabolic steroid 5α-androst-2-en-17-one (2EN) is sold as a prohormone and has been investigated regarding its potential as a steroidal aromatase inhibitor. The administration of 2EN was detected in...
4.
Goschl L, Gmeiner G, Gartner P, Stadler G, Enev V, Thevis M, et al.
Drug Test Anal
. 2021 Jun;
13(9):1668-1677.
PMID: 34089570
The exogenous anabolic-androgenic steroid (AAS) stanozolol stays one of the most detected substances in professional sports. Its detection is a fundamental part of doping analysis, and the analysis of this...
5.
Schanzer W, Geyer H, Thevis M
Drug Test Anal
. 2020 Jan;
12(5):570-572.
PMID: 31910320
No abstract available.
6.
Piper T, Fussholler G, Schanzer W, Lagojda A, Kuehne D, Thevis M
Drug Test Anal
. 2019 Nov;
11(11-12):1644-1655.
PMID: 31733090
The anabolic-androgenic steroid methylstenbolone (MSTEN; 2α,17α-dimethyl-17β-hydroxy-5α-androst-1-en-3-one) is available as a so-called designer steroid or nutritional supplement. It is occasionally detected in doping control samples, predominantly tested and confirmed as the...
7.
Reichel C, Gmeiner G, Reihlen P, Thevis M, Schanzer W
Methods Mol Biol
. 2018 Nov;
1855:131-149.
PMID: 30426415
PEGylation of recombinant proteins and synthetic peptides aims to generate biopharmaceuticals with altered physical properties. The modification may lead to a prolonged serum half-life caused by decreased receptor-mediated endocytosis and/or...
8.
Piper T, Dib J, Putz M, Fussholler G, Pop V, Lagojda A, et al.
Drug Test Anal
. 2018 Nov;
10(11-12):1646-1656.
PMID: 30379415
A steroidal compound was recently detected in a seized black market product and was identified as (17α,20E)-17,20-[(1-methoxyethylidene) bis (oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester (YK11). This compound is described to possess selective...
9.
Keiler A, Zierau O, Wolf S, Diel P, Schanzer W, Vollmer G, et al.
Toxicol Lett
. 2018 Apr;
292:39-45.
PMID: 29702199
4-Hydroxyandrost-4-ene-3,17-dione, also named formestane, is an irreversible aromatase inhibitor and therapeutically used as anti-breast cancer medication in post-menopausal women. Currently, no therapeutical indication led to approval of its 17-hydroxylated analog...
10.
Walpurgis K, Thomas A, Dellanna F, Schanzer W, Thevis M
Proteomics Clin Appl
. 2017 Dec;
12(3):e1700120.
PMID: 29226558
Purpose: Inhibitors of the ActRII signaling pathways represent promising therapeutics for the treatment of muscular diseases, but also pose risks as performance-enhancing agents in sports. Bimagrumab is a human anti-ActRII...